Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Use of human GH in elderly patients with accidental hip fracture.

Van der Lely AJ, Lamberts SW, Jauch KW, Swierstra BA, Hertlein H, Danielle De Vries D, Birkett MA, Bates PC, Blum WF, Attanasio AF.

Eur J Endocrinol. 2000 Nov;143(5):585-92.

2.

The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.

Bach MA, Rockwood K, Zetterberg C, Thamsborg G, Hébert R, Devogelaer JP, Christiansen JS, Rizzoli R, Ochsner JL, Beisaw N, Gluck O, Yu L, Schwab T, Farrington J, Taylor AM, Ng J, Fuh V; MK 0677 Hip Fracture Study Group.

J Am Geriatr Soc. 2004 Apr;52(4):516-23.

PMID:
15066065
3.

Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.

Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, Adams S, Broos P, Lenaerts J, Raus J, Vanderschueren D, Geusens P.

J Clin Endocrinol Metab. 2002 Apr;87(4):1593-9.

PMID:
11932288
4.

Positive effects of short-term growth hormone treatment on lean body mass and BMC after a hip fracture: a double-blind placebo-controlled pilot study in 20 patients.

Hedström M, Sääf M, Brosjö E, Hurtig C, Sjöberg K, Wesslau A, Dalén N.

Acta Orthop Scand. 2004 Aug;75(4):394-401.

PMID:
15370581
5.

Nutritional supplementation of elderly hip fracture patients. A randomized, double-blind, placebo-controlled trial.

Espaulella J, Guyer H, Diaz-Escriu F, Mellado-Navas JA, Castells M, Pladevall M.

Age Ageing. 2000 Sep;29(5):425-31.

PMID:
11108415
6.

Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture.

Yeo AL, Levy D, Martin FC, Sönksen P, Sturgess I, Wheeler MM, Young A.

Growth Horm IGF Res. 2003 Dec;13(6):361-70.

PMID:
14624771
7.

Growth hormone increases breast milk volumes in mothers of preterm infants.

Gunn AJ, Gunn TR, Rabone DL, Breier BH, Blum WF, Gluckman PD.

Pediatrics. 1996 Aug;98(2 Pt 1):279-82.

PMID:
8692630
8.

A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients.

Chu LW, Lam KS, Tam SC, Hu WJ, Hui SL, Chiu A, Chiu KC, Ng P.

J Clin Endocrinol Metab. 2001 May;86(5):1913-20.

PMID:
11344184
9.
10.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001. Epub 2008 Feb 20.

PMID:
18282776
12.

Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations.

Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D.

Clin Endocrinol (Oxf). 1993 Oct;39(4):417-25.

PMID:
8287568
13.

MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study.

Adunsky A, Chandler J, Heyden N, Lutkiewicz J, Scott BB, Berd Y, Liu N, Papanicolaou DA.

Arch Gerontol Geriatr. 2011 Sep-Oct;53(2):183-9. doi: 10.1016/j.archger.2010.10.004. Epub 2010 Nov 9.

PMID:
21067829
14.

Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries.

Roth E, Valentini L, Semsroth M, Hölzenbein T, Winkler S, Blum WF, Ranke MB, Schemper M, Hammerle A, Karner J.

J Trauma. 1995 Jan;38(1):136-41.

PMID:
7538170
15.

Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.

Sääf M, Hilding A, Thorën M, Troell S, Hall K.

Eur J Endocrinol. 1999 May;140(5):390-9.

16.

Anabolic steroids for rehabilitation after hip fracture in older people.

Farooqi V, van den Berg ME, Cameron ID, Crotty M.

Cochrane Database Syst Rev. 2014 Oct 6;(10):CD008887. doi: 10.1002/14651858.CD008887.pub2. Review.

PMID:
25284341
17.

Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.

Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.

Clin Nephrol. 1999 Aug;52(2):103-9.

PMID:
10480221
18.
19.

Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.

Ellis KJ, Lee PD, Pivarnik JM, Bukar JG, Gesundheit N.

J Clin Endocrinol Metab. 1996 Aug;81(8):3033-8.

PMID:
8768870
20.

Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.

Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R.

J Clin Endocrinol Metab. 1994 Nov;79(5):1361-6.

PMID:
7525633

Supplemental Content

Support Center